| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
| (30) |
Priority: |
05.01.2018 CN 201810012284
|
| (43) |
Date of publication of application: |
|
23.09.2020 Bulletin 2020/39 |
| (73) |
Proprietor: Shandong Danhong Pharmaceutical Co., Ltd. |
|
Heze, Shandong 274000 (CN) |
|
| (72) |
Inventors: |
|
- WU, Chengde
Shanghai 200131 (CN)
- MAO, Qinghua
Shanghai 200131 (CN)
- LI, Yi
Shanghai 200131 (CN)
- YU, Tao
Shanghai 200131 (CN)
- CHEN, Shuhui
Shanghai 200131 (CN)
|
| (74) |
Representative: Groth & Co. KB |
|
P.O. Box 6107 102 32 Stockholm 102 32 Stockholm (SE) |
| (56) |
References cited: :
EP-A1- 2 634 184 WO-A1-2015/032272 CN-A- 101 503 399 CN-A- 102 453 026 CN-A- 104 109 154
|
EP-A1- 2 661 256 WO-A2-2008/042688 CN-A- 102 146 066 CN-A- 103 458 875
|
|
| |
|
|
|
|